Sections
Title | Starting Page | Number of Pages |
---|
Table of Contents | 2 | 4 |
List of Tables | 4 | 1 |
List of Figures | 5 | 1 |
Affymetrix, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
Affymetrix, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 | 7 | 1 |
Affymetrix, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
Affymetrix, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 | 9 | 1 |
Affymetrix, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 | 10 | 2 |
Affymetrix, Inc., Medical Equipment, Deal Details | 12 | 31 |
Venture Financing | 12 | 1 |
Eureka Genomics Raises US$3.7 Million In Private Financing | 12 | 1 |
Partnerships | 13 | 1 |
Affymetrix Enters into Licensing Agreement with Peptide Groove | 13 | 1 |
Affymetrix Enters Into Licensing Agreement With DNA Link To Develop Forensic And Other Diagnostic Tests | 14 | 1 |
Affymetrix Expands Licensing Agreement With Siemens Healthcare For Branched DNA Technology | 15 | 1 |
Affymetrix Enters Into Licensing Agreement With Genisphere | 16 | 1 |
Affymetrix Enters Into An Agreement With Signature Diagnostics | 17 | 1 |
Affymetrix Enters into Agreement with Reveal Biosciences | 18 | 1 |
XRGenomics Enters into Research Agreement with Affymetrix | 19 | 1 |
Affymetrix Enters into Distribution Agreement with Luminex | 20 | 1 |
Cytox Enters into Joint Development Partnership with Affymetrix | 21 | 1 |
Affymetrix Enters Into Integration Agreement With CollabRx | 22 | 1 |
Ingenuity Systems Enters Into Co-Promotion Agreement With Affymetrix For Research Tools | 23 | 1 |
Affymetrix Enters Into Agreement With Hamilton Robotics To Develop Cytogenetics Assay | 24 | 1 |
Affymetrix Enters Into Co-Development Agreement With Pathgen Dx | 25 | 1 |
Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests | 26 | 1 |
Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems | 27 | 1 |
Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell Technology | 28 | 1 |
Baylor Research Enters Into Co-Development Agreement With Eureka Genomics | 29 | 1 |
Affymetrix Enters Into Distribution Agreement With Thermo Fisher | 30 | 1 |
TriLink BioTechnologies Signs An Agreement With Affymetrix | 31 | 1 |
Equity Offering | 32 | 1 |
Affymetrix to Raise USD50 Million in Private Placement of Shares | 32 | 2 |
Affymetrix Files Registration Statement For Public Offering Of Securities For US$200 Million | 34 | 1 |
Debt Offering | 35 | 1 |
Affymetrix Completes Public Offering Of Notes Due 2019 For US$105 Million | 35 | 2 |
Acquisition | 37 | 1 |
Thermo Fisher Scientific Acquires Affymetrix for up to USD1.3 Billion | 37 | 2 |
Origin Technologies Withdraws Plan to Acquire Affymetrix | 39 | 2 |
Affymetrix Completes Acquisition Of eBioscience For US$315 Million | 41 | 2 |
Affymetrix, Inc. - Key Competitors | 43 | 1 |
Key Employees | 44 | 1 |
Locations And Subsidiaries | 45 | 2 |
Head Office | 45 | 1 |
Other Locations &Subsidiaries | 45 | 2 |
Recent Developments | 47 | 1 |
Financial Announcements | 47 | 1 |
Feb 17, 2016: Affymetrix Reports Fourth Quarter 2015 Operating Results | 47 | 2 |
Oct 28, 2015: Affymetrix Reports Third Quarter 2015 Operating Results | 49 | 1 |
Jul 29, 2015: Affymetrix Reports Second Quarter 2015 Operating Results | 50 | 1 |
Apr 29, 2015: Affymetrix Reports First Quarter 2015 Operating Results | 51 | 2 |
Feb 04, 2015: Affymetrix Reports Fourth Quarter and Fiscal Year 2014 Results | 53 | 2 |
Jan 12, 2015: Affymetrix Announces Preliminary Fourth Quarter 2014 Revenue of Approximately $93 Million and the Appointment of Merilee Raines to the Board of Directors | 55 | 1 |
Corporate Communications | 56 | 1 |
May 18, 2015: Affymetrix Appoints Riccardo Pigliucci to Board of Directors | 56 | 1 |
Legal and Regulatory | 57 | 1 |
Oct 13, 2015: ENZO Biochem Reaches $10 Million Patent Infringement Settlement with Affymetrix | 57 | 1 |
Product News | 58 | 1 |
Mar 08, 2016: Affymetrix Receives Grant for Non-Invasive Genomic Profiling of Bladder Cancer | 58 | 1 |
Oct 27, 2015: Affymetrix and Athletigen Partner to Advance Genetics in Human Athletic Performance | 59 | 1 |
May 07, 2015: N-of-One To Provide CNV Analysis Interpretation For Affymetrix s OncoScan Kit | 60 | 1 |
Other Significant Developments | 61 | 1 |
Jan 30, 2015: Affymetrix Chairman and Founder to Retire from Board of Directors | 61 | 1 |
Appendix | 62 | 1 |
Methodology | 62 | 1 |
About GlobalData | 62 | 1 |
Contact Us | 62 | 1 |
Disclaimer | 62 | 1 |